% | $
Quotes you view appear here for quick access.

SciClone Pharmaceuticals, Inc. Message Board

  • being_and_machine being_and_machine Jun 10, 2005 10:21 AM Flag

    SCLN to drop

    Let's not forget the PhII results from the Mexican study were far from conclusive. On an ITT basis, only 4 of 25 (16%) patients showed an SVR at week 72. Furthermore, the responders may have had a low viral load at baseline-which would skew interpretation. The fact of the matter is no one is going to buy SciClone. Who would buy them for a huge question mark? No one knows how the ongoing Phase III studies are going (blinded). I suspect these trials will fail to show superiority of the triple combo over standard of care. The Phase II results certainly seem to suggest it. Best of luck to the longs at this price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.125+0.095(+0.73%)May 27 4:00 PMEDT